Provided by Tiger Trade Technology Pte. Ltd.

Evaxion Biotech A/S

3.20
+0.02000.63%
Post-market: 3.200.00000.00%19:38 EDT
Volume:33.92K
Turnover:109.54K
Market Cap:26.69M
PE:-2.94
High:3.28
Open:3.23
Low:3.16
Close:3.18
52wk High:12.15
52wk Low:2.77
Shares:8.34M
Float Shares:5.53M
Volume Ratio:0.87
T/O Rate:0.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0886
EPS(LYR):-1.2027
ROE:-109.86%
ROA:-25.97%
PB:2.80
PE(LYR):-2.66

Loading ...

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading

MT Newswires Live
·
Apr 24

Evaxion Price Target Maintained With a $16.00/Share by HC Wainwright & Co.

Dow Jones
·
Apr 24

Evaxion shareholders adopted 2025 annual report at annual general meeting

Reuters
·
Apr 22

European Equities Traded in the US as American Depositary Receipts Sharply Lower in Tuesday Trading

MT Newswires Live
·
Apr 21

Evaxion says EVX-01 demonstrates 86% vaccine target precision in trial

TIPRANKS
·
Apr 18

Evaxion’s AI-Immunology™ Platform Demonstrates 86% Vaccine Target Precision in Phase 2 Personalized Cancer Vaccine Trial

THOMSON REUTERS
·
Apr 18

Evaxion data show AI-Immunology platform designs glioblastoma vaccine targets, AACR presentation pending

Reuters
·
Apr 18

Evaxion Approves 2025 Report and Refreshes Board at April 16 AGM

TIPRANKS
·
Apr 17

Evaxion elects Jens Bitsch Nørhave to board of directors

Reuters
·
Apr 16

Evaxion held annual general meeting

Reuters
·
Apr 16

Evaxion concludes Annual General Meeting

GlobeNewswire
·
Apr 16

European Equities Traded in the US as ADRs Rise in Tuesday Trading

MT Newswires Live
·
Apr 14

European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading

MT Newswires Live
·
Apr 13

European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

MT Newswires Live
·
Apr 09

Evaxion Biotech reports last patient visit in one-year extension of EVX-01 trial

TIPRANKS
·
Apr 07

Evaxion completes phase 2 EVX-01 trial extension; three-year data due H2 2026

Reuters
·
Apr 07